| Year |
Citation |
Score |
| 1995 |
Edelberg JM, Pizzo SV. Lipoprotein (a) in the regulation of fibrinolysis Journal of Atherosclerosis and Thrombosis. 2: S5-7. PMID 9225222 DOI: 10.5551/Jat1994.2.Supplement1_S5 |
0.605 |
|
| 1995 |
Edelberg JM, Sane DC, Pizzo SV. Vascular regulation of plasminogen activator inhibitor-1 activity. Seminars in Thrombosis and Hemostasis. 20: 319-23. PMID 7899861 DOI: 10.1055/S-2007-1001920 |
0.495 |
|
| 1994 |
Edelberg J, Pizzo SV. Lipoprotein (a) regulates plasmin generation and inhibition. Chemistry and Physics of Lipids. 363-8. PMID 8187236 DOI: 10.1016/0009-3084(94)90158-9 |
0.619 |
|
| 1993 |
Edelberg JM, Lee YJ, Young TN, Pizzo SV. Lipoprotein (a): Purification and kinetic analysis Methods in Enzymology. 223: 272-288. PMID 8271958 DOI: 10.1016/0076-6879(93)23051-N |
0.583 |
|
| 1992 |
Edelberg JM, Pizzo SV. Lipoprotein(a) inhibits plasminogen activation in a template-dependent manner. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 2: 759-64. PMID 1839224 DOI: 10.1097/00001721-199112000-00010 |
0.626 |
|
| 1992 |
Edelberg J, Pizzo SV. Why is lipoprotein(a) relevant to thrombosis? The American Journal of Clinical Nutrition. 56: 791S-792S. PMID 1414982 DOI: 10.1093/Ajcn/56.4.791S |
0.486 |
|
| 1992 |
Young TN, Edelberg JM, Stack S, Pizzo SV. Ionic modulation of the effects of heparin on plasminogen activation by tissue plasminogen activator: The effects of ionic strength, divalent cations, and chloride Archives of Biochemistry and Biophysics. 296: 530-538. PMID 1385938 DOI: 10.1016/0003-9861(92)90607-X |
0.539 |
|
| 1992 |
Edelberg JM, Pizzo SV. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin. The Biochemical Journal. 79-84. PMID 1381585 DOI: 10.1042/Bj2860079 |
0.487 |
|
| 1992 |
Edelberg J, Pizzo S. Lipoprotein(A) regulates the rate of plasmin generation and inhibition Thrombosis Research. 65: S95. DOI: 10.1016/0049-3848(92)90503-3 |
0.449 |
|
| 1991 |
Edelberg JM, Conrad HE, Pizzo SV. Heparin oligosaccharides enhance tissue-type plasminogen activator: a correlation between oligosaccharide length and stimulation of plasminogen activation. Biochemistry. 30: 10999-1003. PMID 1932024 DOI: 10.1021/bi00109a027 |
0.553 |
|
| 1991 |
Edelberg JM, Weissler M, Pizzo SV. Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation. The Biochemical Journal. 785-91. PMID 1829607 DOI: 10.1042/Bj2760785 |
0.612 |
|
| 1991 |
Edelberg J, Pizzo S. Lipoprotein (a): The link between impaired fibrinolysis and atherosclerosis Fibrinolysis. 5: 135-143. DOI: 10.1016/0268-9499(91)90015-V |
0.409 |
|
| 1990 |
Edelberg JM, Enghild JJ, Pizzo SV, Gonzalez-Gronow M. Neonatal plasminogen displays altered cell surface binding and activation kinetics. Correlation with increased glycosylation of the protein. The Journal of Clinical Investigation. 86: 107-12. PMID 2365810 DOI: 10.1172/Jci114671 |
0.43 |
|
| 1990 |
Edelberg JM, Pizzo SV. Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation. Biochemistry. 29: 5906-11. PMID 2143417 DOI: 10.1021/Bi00477A004 |
0.623 |
|
| 1990 |
Edelberg JM, Gonzalez-Gronow M, Pizzo SV. Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator. Thrombosis Research. 57: 155-62. PMID 2137266 DOI: 10.1016/0049-3848(90)90203-O |
0.609 |
|
| 1989 |
Gonzalez-Gronow M, Edelberg JM, Pizzo SV. Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site. Biochemistry. 28: 2374-7. PMID 2543441 DOI: 10.1021/Bi00432A005 |
0.495 |
|
| 1989 |
Edelberg JM, Gonzalez-Gronow M, Pizzo SV. Lipoprotein a inhibits streptokinase-mediated activation of human plasminogen. Biochemistry. 28: 2370-4. PMID 2525048 DOI: 10.1021/Bi00432A004 |
0.573 |
|
| Show low-probability matches. |